Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription


3 Ann Intern Med
5 Antiviral Res
1 Biochem Biophys Res Commun
4 Biochemistry (Mosc)
37 BMJ
4 Cell
8 Epidemiol Infect
1 J Exp Med
1 J Gen Virol
1 J Immunol
40 J Infect
4 J Infect Dis
1 J Virol
3 Lancet
1 Lancet Child Adolesc Health
3 Lancet Diabetes Endocrinol
8 Lancet Gastroenterol Hepatol
17 Lancet Glob Health
4 Lancet Infect Dis
14 Lancet Psychiatry
4 Lancet Respir Med
2 MMWR Morb Mortal Wkly Rep
22 N Engl J Med
1 PLoS Biol
1 PLoS Comput Biol
2 PLoS Med
13 PLoS One
1 Proc Natl Acad Sci U S A
7 Vaccine
1 Virology
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. HESSE EM, Navarro RA, Daley MF, Getahun D, et al
    Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Study.
    Ann Intern Med. 2020 Jun 23. doi: 10.7326/M19-3176.
    PubMed         Abstract available

  2. YANG P, Tekwani S, Martin GS
    In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement.
    Ann Intern Med. 2020;172:JC63.
    PubMed         Abstract available

  3. DUGAR SP, Vallabhajosyula S
    Best practice statements and recommendations for caring for critically ill patients with COVID-19.
    Ann Intern Med. 2020;172:JC62.
    PubMed         Abstract available

    Antiviral Res

  4. MANTLO E, Bukreyeva N, Maruyama J, Paessler S, et al
    Antiviral activities of type I interferons to SARS-CoV-2 infection.
    Antiviral Res. 2020;179:104811.
    PubMed         Abstract available

  5. TAKASHITA E, Abe T, Morita H, Nagata S, et al
    Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment.
    Antiviral Res. 2020 Jun 20:104828. doi: 10.1016/j.antiviral.2020.104828.
    PubMed         Abstract available

  6. TAI W, Zhang X, He Y, Jiang S, et al
    Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
    Antiviral Res. 2020 May 13:104820. doi: 10.1016/j.antiviral.2020.104820.
    PubMed         Abstract available

  7. BRAY M, Rayner C, Noel F, Jans D, et al
    Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses.
    Antiviral Res. 2020 Apr 21:104805. doi: 10.1016/j.antiviral.2020.104805.

  8. MATYUSHENKO V, Kotomina T, Kudryavtsev I, Mezhenskaya D, et al
    Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell respo
    Antiviral Res. 2020 Jun 22:104864. doi: 10.1016/j.antiviral.2020.104864.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  9. CHOI JY, Lee HK, Park JH, Cho SJ, et al
    Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
    Biochem Biophys Res Commun. 2020;528:413-419.
    PubMed         Abstract available

    Biochemistry (Mosc)

  10. BORAVLEVA EY, Lunitsin AV, Kaplun AP, Bykova NV, et al
    Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge.
    Biochemistry (Mosc). 2020;85:553-566.
    PubMed         Abstract available

  11. PODSHIVALOV DD, Kirilin EM, Konnov SI, Svedas VK, et al
    Structural Organization and Dynamic Characteristics of the Binding Site for Conformational Rearrangement Inhibitors in Hemagglutinins from H3N2 and H7N9 Influenza Viruses.
    Biochemistry (Mosc). 2020;85:499-506.
    PubMed         Abstract available

    Unique Bipolar Gene Architecture in the RNA Genome of Influenza A Virus.
    Biochemistry (Mosc). 2020;85:387-392.
    PubMed         Abstract available

  13. KIRILIN EM, Svedas VK
    Analysis of Glycosyl-Enzyme Intermediate Formation in the Catalytic Mechanism of Influenza Virus Neuraminidase Using Molecular Modeling.
    Biochemistry (Mosc). 2020;85:490-498.
    PubMed         Abstract available


  14. KINDER F, Harvey A
    Covid-19: the medical students responding to the pandemic.
    BMJ. 2020;369:m2160.

  15. WARREN J
    Pernicious anaemia: self-administration of hydroxocobalamin in the covid-19 crisis.
    BMJ. 2020;369:m2380.

    Minding the epistemic gap in covid-19 and beyond.
    BMJ. 2020;369:m2379.

  17. SAXENA S, Skirrow H, Bedford H
    Routine vaccination during covid-19 pandemic response.
    BMJ. 2020;369:m2392.

  18. GUPTA R, Dhamija RK
    Covid-19: social distancing or social isolation?
    BMJ. 2020;369:m2399.

  19. JULIAO M
    Administration of end-of-life drugs by family caregivers during covid-19: opportunity for future home prescribing plans.
    BMJ. 2020;369:m2408.

  20. TAKHAR A
    Pernicious anaemia: switch to oral B12 supplementation to reduce risk of covid-19 transmission.
    BMJ. 2020;369:m2383.

  21. CHOWDHURY MM, Bevan N, Ryan K
    Covid-19: virtual occupational skin health clinics for healthcare workers.
    BMJ. 2020;369:m2281.

    Covid-19: public health expertise is being sidelined.
    BMJ. 2020;369:m2454.

  23. GREENBERG AL, Greenberg H
    UK's response to covid-19: crude, unadjusted mortality figures are not the whole story.
    BMJ. 2020;369:m2453.

  24. SLINGO M
    Covid-19: now is not the time to judge the UK's response.
    BMJ. 2020;369:m2448.

  25. ABRAHAM-THOMAS N, Vizcaychipi MP
    Let's not forget our female front line.
    BMJ. 2020;369:m2167.

  26. WINTERS M, Oppenheim B, Pick J, Nordenstedt H, et al
    Creating misinformation: how a headline in The BMJ about covid-19 spread virally.
    BMJ. 2020;369:m2384.

    Violence against women in the covid-19 pandemic: we need upstream approaches to break the intergenerational cycle.
    BMJ. 2020;369:m2327.

  28. FIGUEROA JD, Brennan PM, Theodoratou E, Poon MTC, et al
    Distinguishing between direct and indirect consequences of covid-19.
    BMJ. 2020;369:m2377.

  29. VERWEIJ EJ, M'hamdi HI, Steegers EAP, Reiss IKM, et al
    Collateral damage of the covid-19 pandemic: a Dutch perinatal perspective.
    BMJ. 2020;369:m2326.

  30. ANDERSON G, Frank JW, Naylor CD, Wodchis W, et al
    Using socioeconomics to counter health disparities arising from the covid-19 pandemic.
    BMJ. 2020;369:m2149.

  31. KNIGHT M, Bunch K, Vousden N, Morris E, et al
    Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.
    BMJ. 2020;369:m2107.
    PubMed         Abstract available

  32. LAKHANI M, Lakhani S, Lakhani P
    Reimagining healthcare after covid-19: a new normal for medicine.
    BMJ. 2020;369:m2220.

  33. WONG EL, Yeoh EK, Dong D
    Covid-19: transforming healthcare will require collaboration and innovative policies.
    BMJ. 2020;369:m2229.

  34. LOOI MK, Coombes R
    Risky Business: lessons from covid-19.
    BMJ. 2020;369:m2221.

  35. BELL D
    Covid-19: democracy and hard choices in public health.
    BMJ. 2020;369:m2090.

    The "virtual wards" supporting patients with covid-19 in the community.
    BMJ. 2020;369:m2119.

  37. MEGGET K
    Even covid-19 can't kill the anti-vaccination movement.
    BMJ. 2020;369:m2184.

  38. BEANEY T, Salman D, Samee T, Mak V, et al
    Assessment and management of adults with asthma during the covid-19 pandemic.
    BMJ. 2020;369:m2092.

  39. CHANDAN JK, Lynch J, Wilson G, Fisher C, et al
    Covid-19: trainee healthcare scientists are crucial to surviving the long road ahead.
    BMJ. 2020;369:m2235.

  40. VON DADELSZEN P, Khalil A, Wolfe I, Kametas NA, et al
    "Women and children last"-effects of the covid-19 pandemic on reproductive, perinatal, and paediatric health.
    BMJ. 2020;369:m2287.

  41. RAHMAN MS, Lassi ZS, Shariful Islam SM
    Risks to Bangladeshi children and young people during covid-19 outbreak.
    BMJ. 2020;369:m2299.

  42. PATEL P, Hiam L, Sowemimo A, Devakumar D, et al
    Ethnicity and covid-19.
    BMJ. 2020;369:m2282.

    Tackling UK's mortality problem: covid-19 and other causes.
    BMJ. 2020;369:m2295.

  44. GRAY NA, Back AL
    Covid-19 communication aids.
    BMJ. 2020;369:m2255.

  45. LYNCH CA
    Covid-19: Students on standby to help with contract tracing.
    BMJ. 2020;369:m2289.

  46. BHOPAL SS, Bagaria J, Bhopal R
    Risks to children during the covid-19 pandemic: some essential epidemiology.
    BMJ. 2020;369:m2290.

  47. TAN M, He FJ, MacGregor GA
    Obesity and covid-19: the role of the food industry.
    BMJ. 2020;369:m2237.

  48. LIU M, Cheng SZ, Xu KW, Yang Y, et al
    Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.
    BMJ. 2020;369:m2195.
    PubMed         Abstract available

  49. GROVER C
    Efficacy of face masks depends on spatial relation between host and recipient and who is being protected.
    BMJ. 2020;369:m2016.

    UK's alternative scientific advisers put public health first.
    BMJ. 2020;369:m2056.


  51. The Novel Coronavirus Outbreak: What We Know and What We Don't.
    Cell. 2020;180:1034-1036.

  52. ZEGGINI E, Baumann M, Gotz M, Herzig S, et al
    Biomedical Research Goes Viral: Dangers and Opportunities.
    Cell. 2020;181:1189-1193.
    PubMed         Abstract available

  53. ZHANG K, Liu X, Shen J, Li Z, et al
    Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography.
    Cell. 2020;181:1423-1433.
    PubMed         Abstract available

    A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Cell. 2020;181:1194-1199.
    PubMed         Abstract available

    Epidemiol Infect

  55. MIYACHI T, Tanimoto T, Kami M
    Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa.
    Epidemiol Infect. 2020;148:e113.
    PubMed         Abstract available

  56. YU HP, Ma LL, Hung YY, Wang XB, et al
    Application of 'mobile hospital' against 2019-nCoV in China.
    Epidemiol Infect. 2020;148:e111.

  57. THAI PQ, Toan DTT, Son DT, Van HTH, et al
    Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
    Epidemiol Infect. 2020;148:e114.
    PubMed         Abstract available

  58. MCCLOSKEY B, Heymann DL
    SARS to novel coronavirus - old lessons and new lessons.
    Epidemiol Infect. 2020;148:e22.
    PubMed         Abstract available

  59. HAIDER N, Yavlinsky A, Kock R
    Response to 'Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa' (Epidemiology and Infection - HYG-LE-10513-May-20).
    Epidemiol Infect. 2020;148:e112.

  60. WALKER MD, Sulyok M
    Online behavioural patterns for Coronavirus disease 2019 (COVID-19) in the United Kingdom.
    Epidemiol Infect. 2020;148:e110.
    PubMed         Abstract available

  61. MASSAD E, Amaku M, Wilder-Smith A, Costa Dos Santos PC, et al
    Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre. The case of COVID-19.
    Epidemiol Infect. 2020;148:e109.
    PubMed         Abstract available

  62. LIU BM, Yang QQ, Zhao LY, Xie W, et al
    Epidemiological characteristics of COVID-19 patients in convalescence period.
    Epidemiol Infect. 2020;148:e108.
    PubMed         Abstract available

    J Exp Med

  63. STOLLEY JM, Johnston TS, Soerens AG, Beura LK, et al
    Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    J Gen Virol

  64. QIN Z, Qu X, Lei L, Xu L, et al
    Y-Box-Binding Protein 3 (YBX3) Restricts Influenza A Virus by Interacting with Viral Ribonucleoprotein Complex and Imparing its Function.
    J Gen Virol. 2020;101:385-398.
    PubMed         Abstract available

    J Immunol

  65. MANJILI RH, Zarei M, Habibi M, Manjili MH, et al
    COVID-19 as an Acute Inflammatory Disease.
    J Immunol. 2020;205:12-19.
    PubMed         Abstract available

    J Infect

  66. WANG JT, Lin YY, Chang SY, Yeh SH, et al
    The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30159.

  67. ZHU Y, Gao ZH, Liu YL, Xu DY, et al
    Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30161.

  68. LI W, Zhang J, Xiao S, Sun L, et al
    Characteristics of health worker fatality in China during the outbreak of COVID-19 infection.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30158.

  69. GE R, Qi Y, Yan Y, Tian M, et al
    The role of close contacts tracking management in COVID-19 prevention: A cluster investigation in Jiaxing, China.
    J Infect. 2020 Apr 5. pii: S0163-4453(20)30144.

  70. SUN S, Yu K, Xie Z, Pan X, et al
    China empowers Internet hospital to fight against COVID-19.
    J Infect. 2020 Apr 3. pii: S0163-4453(20)30183.

  71. XIAO DAT, Gao DC, Zhang DS
    Profile of Specific Antibodies to SARS-CoV-2: The First Report.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30138.

  72. ZHANG Z, Yao W, Wang Y, Long C, et al
    Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30145.

  73. ZHOU B, She J, Wang Y, Ma X, et al
    The Clinical Characteristics of Myocardial injury 1 in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30149.

  74. YANG Z, Liu J, Zhou Y, Zhao X, et al
    The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
    J Infect. 2020;81:e13-e20.
    PubMed         Abstract available

  75. HILL DKJ, Russell DCD, Clifford DS, Templeton DK, et al
    The index case of SARS-CoV-2 in Scotland: a case report.
    J Infect. 2020 Mar 20. pii: S0163-4453(20)30148.
    PubMed         Abstract available

  76. DENG L, Li C, Zeng Q, Liu X, et al
    Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30113.
    PubMed         Abstract available

  77. FANG Z, Zhang Y, Hang C, Zhang W, et al
    Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30139.

  78. TU H, Tu S, Gao S, Shao A, et al
    Current epidemiological and clinical features of COVID-19; a global perspective from China.
    J Infect. 2020;81:1-9.
    PubMed         Abstract available

  79. LIU L, Quan J, Lv J, Long S, et al
    A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    J Infect. 2020;81:147-178.

  80. WANG Z, Ma W, Zheng X, Wu G, et al
    Household transmission of SARS-CoV-2.
    J Infect. 2020;81:179-182.
    PubMed         Abstract available

  81. ZENG Z, Chen L, Pan Y, Deng Q, et al
    Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    J Infect. 2020;81:e80-e81.

  82. MENG H, Xiong R, He R, Lin W, et al
    CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30211.
    PubMed         Abstract available

  83. AZZI L, Carcano G, Gianfagna F, Grossi P, et al
    J Infect. 2020 Apr 13. pii: S0163-4453(20)30213.
    PubMed         Abstract available

  84. LV B, Li Z, Chen Y, Long C, et al
    Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks.
    J Infect. 2020 Apr 14. pii: S0163-4453(20)30157.

  85. KENYON C
    Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30215.

  86. GODAERT L, Proye E, Demoustier-Tampere D, Coulibaly PS, et al
    Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30217.

  87. LIU X, Zhou H, Zhou Y, Wu X, et al
    Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30216.

  88. XU B, Fan CY, Wang AL, Zou YL, et al
    Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    J Infect. 2020;81:e51-e60.
    PubMed         Abstract available

  89. LI H, Chen K, Liu M, Xu H, et al
    The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.
    J Infect. 2020 Apr 20. pii: S0163-4453(20)30207.
    PubMed         Abstract available

  90. CHU Y, Li T, Fang Q, Wang X, et al
    Clinical features of critically ill patients with confirmed COVID-19.
    J Infect. 2020 Apr 28. pii: S0163-4453(20)30150.

  91. WU J, Liang J, Zhou H, Peng F, et al
    Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30238.

  92. MINOTTI C, Tirelli F, Barbieri E, Giaquinto C, et al
    How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30237.
    PubMed         Abstract available

  93. CHENG VCC, Wong SC, Chuang VWM, So SYC, et al
    The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30235.
    PubMed         Abstract available

  94. YANG H, Sun G, Tang F, Peng M, et al
    Clinical Features and Outcomes of Pregnant Women Suspected of Coronavirus Disease 2019.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30212.
    PubMed         Abstract available

  95. DU X, Yu X, Li Q, Li X, et al
    Duration for carrying SARS-CoV-2 in COVID-19 patients.
    J Infect. 2020;81:e78-e79.

  96. ZUIN M, Rigatelli G, Zuliani G, Rigatelli A, et al
    Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.
    J Infect. 2020;81:e84-e86.

  97. LIU Y, Du X, Chen J, Jin Y, et al
    Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    J Infect. 2020;81:e6-e12.
    PubMed         Abstract available

  98. JIANG DM
    Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19).
    J Infect. 2020 Apr 11. pii: S0163-4453(20)30152.

  99. WEI YY, Wang RR, Zhang DW, Tu YH, et al
    Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30219.

  100. FANG X, Mei Q, Yang T, Li L, et al
    Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
    J Infect. 2020;81:147-178.

  101. BENVENUTO D, Angeletti S, Giovanetti M, Bianchi M, et al
    Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.
    J Infect. 2020;81:e24-e27.
    PubMed         Abstract available

  102. ZHU Z, Lu Z, Xu T, Chen C, et al
    Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
    J Infect. 2020;81:e21-e23.
    PubMed         Abstract available

  103. LU Y, Zhang L
    Social media WeChat infers the development trend of COVID-19.
    J Infect. 2020;81:e82-e83.

  104. PAN Y, Li X, Yang G, Fan J, et al
    Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.
    J Infect. 2020;81:e28-e32.
    PubMed         Abstract available

  105. HE M, Xiong J, Huang S, Bian Y, et al
    Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19.
    J Infect. 2020;81:e75-e77.

    J Infect Dis

  106. COWLING BJ, Aiello AE
    Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
    J Infect Dis. 2020;221:1749-1751.

  107. MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
    Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
    J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
    PubMed         Abstract available

  108. JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
    Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
    J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
    PubMed         Abstract available

  109. GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
    Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    J Infect Dis. 2020;221:882-889.
    PubMed         Abstract available

    J Virol

  110. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.


  111. POORTMANS PM, Guarneri V, Cardoso MJ
    Cancer and COVID-19: what do we really know?
    Lancet. 2020 May 29. pii: S0140-6736(20)31240.

  112. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31282.

  113. NAY O, Kieny MP, Marmora L, Kazatchkine M, et al
    The WHO we want.
    Lancet. 2020;395:1818-1820.

    Lancet Child Adolesc Health

  114. WANG J, Qi H, Bao L, Li F, et al
    A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units.
    Lancet Child Adolesc Health. 2020 Feb 7. pii: S2352-4642(20)30040.

    Lancet Diabetes Endocrinol

  115. ISIDORI AM, Pofi R, Hasenmajer V, Lenzi A, et al
    Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.
    Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30149.

  116. BORNSTEIN SR, Rubino F, Khunti K, Mingrone G, et al
    Practical recommendations for the management of diabetes in patients with COVID-19.
    Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30152.
    PubMed         Abstract available

  117. FLINT SW, Tahrani AA
    COVID-19 and obesity-lack of clarity, guidance, and implications for care.
    Lancet Diabetes Endocrinol. 2020 Apr 29. pii: S2213-8587(20)30156.

    Lancet Gastroenterol Hepatol

  118. WEBB GJ, Moon AM, Barnes E, Barritt AS, et al
    Determining risk factors for mortality in liver transplant patients with COVID-19.
    Lancet Gastroenterol Hepatol. 2020 Apr 24. pii: S2468-1253(20)30125.

  119. FIORINO G, Peyrin-Biroulet L, Danese S
    Protecting patients with IBD during the COVID-19 pandemic.
    Lancet Gastroenterol Hepatol. 2020 May 19. pii: S2468-1253(20)30152.

  120. HAN J, Zhu L, Wang Y, Zeng Z, et al
    Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19.
    Lancet Gastroenterol Hepatol. 2020 May 4. pii: S2468-1253(20)30133.

  121. SEGAL JP, Quraishi MN, Bhala N, Brookes MJ, et al
    Prevention of COVID-19 in patients with IBD.
    Lancet Gastroenterol Hepatol. 2020 May 19. pii: S2468-1253(20)30153.

  122. YANG L, Tu L
    Implications of gastrointestinal manifestations of COVID-19.
    Lancet Gastroenterol Hepatol. 2020 May 12. pii: S2468-1253(20)30132.

  123. NG SC, Chan FKL, Chan PKS
    Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.
    Lancet Gastroenterol Hepatol. 2020 Apr 22. pii: S2468-1253(20)30124.

  124. DING NS, An P, Dong W, Ding Y, et al
    Prevention of COVID-19 in patients with IBD - Authors' reply.
    Lancet Gastroenterol Hepatol. 2020;5:640-641.

  125. LANCASTER K, Rhodes T
    Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy.
    Lancet Gastroenterol Hepatol. 2020;5:641-642.

    Lancet Glob Health

  126. SONENTHAL PD, Masiye J, Kasomekera N, Marsh RH, et al
    COVID-19 preparedness in Malawi: a national facility-based critical care assessment.
    Lancet Glob Health. 2020 May 25. pii: S2214-109X(20)30250.

  127. MENENDEZ C, Gonzalez R, Donnay F, Leke RGF, et al
    Avoiding indirect effects of COVID-19 on maternal and child health.
    Lancet Glob Health. 2020 May 12. pii: S2214-109X(20)30239.

  128. KELLEY M, Ferrand RA, Muraya K, Chigudu S, et al
    An appeal for practical social justice in the COVID-19 global response in low-income and middle-income countries.
    Lancet Glob Health. 2020 May 14. pii: S2214-109X(20)30249.

  129. HAMAL PK, Chaurasia RB, Pokhrel N, Pandey D, et al
    An affordable videolaryngoscope for use during the COVID-19 pandemic.
    Lancet Glob Health. 2020;8:e893-e894.

  130. KARAMOUZIAN M, Madani N
    COVID-19 response in the Middle East and north Africa: challenges and paths forward.
    Lancet Glob Health. 2020 May 14. pii: S2214-109X(20)30233.

  131. SENGHORE M, Savi MK, Gnangnon B, Hanage WP, et al
    Leveraging Africa's preparedness towards the next phase of the COVID-19 pandemic.
    Lancet Glob Health. 2020 May 14. pii: S2214-109X(20)30234.

    Publishing in the time of COVID-19.
    Lancet Glob Health. 2020;8:e860.

    Use of the Demographic and Health Survey framework as a population surveillance strategy for COVID-19.
    Lancet Glob Health. 2020 Apr 29. pii: S2214-109X(20)30213.

  134. MEHTAR S, Preiser W, Lakhe NA, Bousso A, et al
    Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries.
    Lancet Glob Health. 2020 Apr 28. pii: S2214-109X(20)30212.

  135. KHAN M, Shanks S
    Decolonising COVID-19: delaying external debt repayments.
    Lancet Glob Health. 2020 Jun 1. pii: S2214-109X(20)30253.

  136. AMON JJ
    Human rights protections are needed alongside PPE for health-care workers responding to COVID-19.
    Lancet Glob Health. 2020 May 25. pii: S2214-109X(20)30252.

  137. ROBERTON T, Carter ED, Chou VB, Stegmuller AR, et al
    Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study.
    Lancet Glob Health. 2020 May 12. pii: S2214-109X(20)30229.
    PubMed         Abstract available

  138. FORE HH
    A wake-up call: COVID-19 and its impact on children's health and wellbeing.
    Lancet Glob Health. 2020 May 12. pii: S2214-109X(20)30238.

  139. JARQUIN MC, Prado AM, Gallo Marin B
    Nicaragua's response to COVID-19 - Authors' reply.
    Lancet Glob Health. 2020 Apr 30. pii: S2214-109X(20)30220.

  140. PERRY J
    Nicaragua's response to COVID-19.
    Lancet Glob Health. 2020 Apr 30. pii: S2214-109X(20)30218.

  141. DITTRICH S, Lamy M, Acharya S, Thu HK, et al
    Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic.
    Lancet Glob Health. 2020 Apr 24. pii: S2214-109X(20)30210.

  142. BUEKENS P, Alger J, Breart G, Cafferata ML, et al
    A call for action for COVID-19 surveillance and research during pregnancy.
    Lancet Glob Health. 2020 Apr 22. pii: S2214-109X(20)30206.

    Lancet Infect Dis

  143. LI J, Li JJ, Xie X, Cai X, et al
    Game consumption and the 2019 novel coronavirus.
    Lancet Infect Dis. 2020;20:275-276.

  144. BURKI T
    Outbreak of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:292-293.

    Challenges of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:261.

  146. BASTOLA A, Sah R, Rodriguez-Morales AJ, Lal BK, et al
    The first 2019 novel coronavirus case in Nepal.
    Lancet Infect Dis. 2020;20:279-280.

    Lancet Psychiatry

  147. SMITH S, Gilbert S, Ariyo K, Arundell LL, et al
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e40.

  148. FIRTH J, Torous J
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e39.

  149. BELL G, Deshpande M, Hales H, Harding D, et al
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e37-e38.

  150. SINGH I, Pavarini G, Juma D, Farmer M, et al
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e36.

  151. MCALONAN GM, Murphy DGM, Edwards AD
    Multidisciplinary: research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e35.

  152. NAJAM S
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e34.

  153. MORGAN C, Rose N
    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e33.

    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e42.

    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e43.

  156. STOSSEL L
    New York, USA.
    Lancet Psychiatry. 2020;7:486.

  157. O'CONNOR RC, Hotopf M, Worthman CM, Perry VH, et al
    Multidisciplinary research priorities for the COVID-19 pandemic - Authors' reply.
    Lancet Psychiatry. 2020;7:e44-e45.

  158. TERRANOVA C, Terranova O
    COVID-19 and the death of older people in Italy's rest homes. Is a judicial turmoil the answer?
    Lancet Psychiatry. 2020;7:e46.

  159. PIERCE M, McManus S, Jessop C, John A, et al
    Says who? The significance of sampling in mental health surveys during COVID-19.
    Lancet Psychiatry. 2020 Jun 2. pii: S2215-0366(20)30237.

    Multidisciplinary research priorities for the COVID-19 pandemic.
    Lancet Psychiatry. 2020;7:e41.

    Lancet Respir Med

  161. BURKI TK
    Coronavirus in China.
    Lancet Respir Med. 2020;8:238.

  162. RONCO C, Navalesi P, Vincent JL
    Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.
    Lancet Respir Med. 2020 Feb 6. pii: S2213-2600(20)30060.

  163. KIRBY T
    Australian Government releases face masks to protect against coronavirus.
    Lancet Respir Med. 2020;8:239.

  164. CHANG, Xu H, Rebaza A, Sharma L, et al
    Protecting health-care workers from subclinical coronavirus infection.
    Lancet Respir Med. 2020;8:e13.

    MMWR Morb Mortal Wkly Rep

  165. STOKES EK, Zambrano LD, Anderson KN, Marder EP, et al
    Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:759-765.
    PubMed         Abstract available

  166. CZEISLER ME, Tynan MA, Howard ME, Honeycutt S, et al
    Public Attitudes, Behaviors, and Beliefs Related to COVID-19, Stay-at-Home Orders, Nonessential Business Closures, and Public Health Guidance - United States, New York City, and Los Angeles, May 5-12, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:751-758.
    PubMed         Abstract available

    N Engl J Med

  167. GELERIS J, Sun Y, Platt J, Zucker J, et al
    Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 May 7. doi: 10.1056/NEJMoa2012410.
    PubMed         Abstract available

  168. REYNOLDS HR, Adhikari S, Pulgarin C, Troxel AB, et al
    Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2008975.
    PubMed         Abstract available

  169. MANCIA G, Rea F, Ludergnani M, Apolone G, et al
    Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2006923.
    PubMed         Abstract available

  170. JARCHO JA, Ingelfinger JR, Hamel MB, D'Agostino RB Sr, et al
    Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMe2012924.

  171. AKALIN E, Azzi Y, Bartash R, Seethamraju H, et al
    Covid-19 and Kidney Transplantation.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMc2011117.

    Waiting for Something Positive.
    N Engl J Med. 2020;382:e89.

  173. BANGALORE S, Sharma A, Slotwiner A, Yatskar L, et al
    ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009020.

  174. CHEN L, Li Q, Zheng D, Jiang H, et al
    Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009226.

  175. GALLAGHER TH, Schleyer AM
    "We Signed Up for This!" - Student and Trainee Responses to the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 8. doi: 10.1056/NEJMp2005234.

  176. GRUBER J, Sommers BD
    Paying for Medicaid - State Budgets and the Case for Expansion in the Time of Coronavirus.
    N Engl J Med. 2020;382:2280-2282.

  177. RUBIN EJ, Harrington DP, Hogan JW, Gatsonis C, et al
    The Urgency of Care during the Covid-19 Pandemic - Learning as We Go.
    N Engl J Med. 2020 May 7. doi: 10.1056/NEJMe2015903.

  178. BONOVAS S, Piovani D
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.

  179. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at SARS-CoV-2 Transmission.
    N Engl J Med. 2020;382:e112.

  180. KAZI DS, Martin LM, Litmanovich D, Pinto DS, et al
    Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.
    N Engl J Med. 2020;382:2354-2364.

    The South African Response to the Pandemic.
    N Engl J Med. 2020;382:e95.

  182. HELMS J, Kremer S, Meziani F
    More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
    N Engl J Med. 2020;382.

    More on Neurologic Features in Severe SARS-CoV-2 Infection.
    N Engl J Med. 2020;382.

  184. LARVIE M, Lev MH, Hess CP
    More on Neurologic Features in Severe SARS-CoV-2 Infection.
    N Engl J Med. 2020;382.

  185. GREIN J, Myers RP, Brainard D
    Compassionate Use of Remdesivir in Covid-19. Reply.
    N Engl J Med. 2020;382.

  186. WU J, Wu B, Lai T
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.

    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.

  188. FATKENHEUER G, Lundgren J
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.

    PLoS Biol

  189. SNIJDER EJ, Limpens RWAL, de Wilde AH, de Jong AWM, et al
    A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.
    PLoS Biol. 2020;18:e3000715.
    PubMed         Abstract available

    PLoS Comput Biol

  190. SAAD-ROY CM, Arinaminpathy N, Wingreen NS, Levin SA, et al
    Implications of localized charge for human influenza A H1N1 hemagglutinin evolution: Insights from deep mutational scans.
    PLoS Comput Biol. 2020;16:e1007892.
    PubMed         Abstract available

    PLoS Med

  191. TRUELOVE S, Abrahim O, Altare C, Lauer SA, et al
    The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study.
    PLoS Med. 2020;17:e1003144.
    PubMed         Abstract available

  192. ZHANG C, Gu J, Chen Q, Deng N, et al
    Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
    PLoS Med. 2020;17:e1003130.
    PubMed         Abstract available

    PLoS One

  193. XING J, Sun N, Xu J, Geng S, et al
    Study of the mental health status of medical personnel dealing with new coronavirus pneumonia.
    PLoS One. 2020;15:e0233145.
    PubMed         Abstract available

  194. WALSH P, Lebedev M, McEligot H, Mutua V, et al
    A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.
    PLoS One. 2020;15:e0230245.
    PubMed         Abstract available

  195. LE YH, Nguyen KC, Coleman KK, Nguyen TT, et al
    Virus detections among patients with severe acute respiratory illness, Northern Vietnam.
    PLoS One. 2020;15:e0233117.
    PubMed         Abstract available

  196. HERRERA AL, Van Hove C, Hanson M, Dale JB, et al
    Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.
    PLoS One. 2020;15:e0235139.
    PubMed         Abstract available

  197. BLESER WK, Salmon DA, Miranda PY
    A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines.
    PLoS One. 2020;15:e0234466.
    PubMed         Abstract available

  198. OKOLI GN, Lam OLT, Racovitan F, Reddy VK, et al
    Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors.
    PLoS One. 2020;15:e0234702.
    PubMed         Abstract available

  199. CHENG KJG, Rivera AS, Lam HY, Ulitin AR, et al
    Influenza-associated excess mortality in the Philippines, 2006-2015.
    PLoS One. 2020;15:e0234715.
    PubMed         Abstract available

    A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases.
    PLoS One. 2020;15:e0233146.
    PubMed         Abstract available

  201. GARBE L, Rau R, Toppe T
    Influence of perceived threat of Covid-19 and HEXACO personality traits on toilet paper stockpiling.
    PLoS One. 2020;15:e0234232.
    PubMed         Abstract available

  202. CHIRKOVA T, Ha B, Rimawi BH, Oomens AGP, et al
    In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    PLoS One. 2020;15:e0229660.
    PubMed         Abstract available

  203. LAMB LE, Bartolone SN, Ward E, Chancellor MB, et al
    Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification.
    PLoS One. 2020;15:e0234682.
    PubMed         Abstract available

  204. LEE MH, Lee GA, Lee SH, Park YH, et al
    A systematic review on the causes of the transmission and control measures of outbreaks in long-term care facilities: Back to basics of infection control.
    PLoS One. 2020;15:e0229911.
    PubMed         Abstract available

  205. ZHAO XN, Zhang HJ, Li D, Zhou JN, et al
    Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018.
    PLoS One. 2020;15:e0234869.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  206. CEBALLOS G, Ehrlich PR, Raven PH
    Vertebrates on the brink as indicators of biological annihilation and the sixth mass extinction.
    Proc Natl Acad Sci U S A. 2020;117:13596-13602.
    PubMed         Abstract available


  207. GRIECO L, Panovska-Griffiths J, van Leeuwen E, Grove P, et al
    Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context.
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30805.
    PubMed         Abstract available

  208. MOEHLING KK, Zimmerman RK, Nowalk MP, Jeng Lin C, et al
    A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
    Vaccine. 2020 Jun 21. pii: S0264-410X(20)30796.
    PubMed         Abstract available

  209. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30735.
    PubMed         Abstract available

  210. ULYTE A, Wei W, Gruebner O, Bahler C, et al
    Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30791.
    PubMed         Abstract available

  211. MUNOZ FM, Patel SM, Jackson LA, Swamy GK, et al
    Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30704.
    PubMed         Abstract available

  212. LAYTON JB, McGrath LJ, Sahrmann JM, Ma Y, et al
    Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30793.
    PubMed         Abstract available

  213. LAMBERT PH, Ambrosino DM, Andersen SR, Baric RS, et al
    Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Vaccine. 2020 May 25. pii: S0264-410X(20)30709.
    PubMed         Abstract available


  214. ROTHAN HA, Stone S, Natekar J, Kumari P, et al
    The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.
    Virology. 2020;547:7-11.
    PubMed         Abstract available

    Virus Res

  215. FANG A, Bi Z, Ye H, Yan L, et al
    SRSF10 inhibits the polymerase activity and replication of avian influenza virus by regulating the alternative splicing of chicken ANP32A.
    Virus Res. 2020 Jun 20:198063. doi: 10.1016/j.virusres.2020.198063.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.